https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
120
 
downloads
8
CITE
How to cite this poster:
Radich JP, Martinelli G, Hochhaus A et al. Response and outcomes to nilotinib at 24 months in patients with imatinib-resistant chronic myeloid leukemia in chronic phase and accelerated phase with and without BCR-ABL mutations. F1000Posters 2010, 1:26 (poster)

Response and outcomes to nilotinib at 24 months in patients with imatinib-resistant chronic myeloid leukemia in chronic phase and accelerated phase with and without BCR-ABL mutations

Jerald P. Radich1, Giovanni Martinelli, Andreas Hochhaus, Enrico Gottardi, Simona Soverini, Susan Branford, Martin C Müller, Lan Beppu, Yaping Shou, Ariful Haque, Richard C. Woodman, Hagop M. Kantarjian, Timothy P. Hughes, Dong-Wook Kim, Giuseppe Saglio
Published 31 Mar 2010
Author Affiliations
  • Metrics
  • 120 Views
  • 8 Downloads
Browse by related subjects
Published 31 Mar 2010

Response and outcomes to nilotinib at 24 months in patients with imatinib-resistant chronic myeloid leukemia in chronic phase and accelerated phase with and without BCR-ABL mutations

[version 1; not peer reviewed]

Jerald P. Radich1, Giovanni Martinelli, Andreas Hochhaus, Enrico Gottardi, Simona Soverini, Susan Branford, Martin C Müller, Lan Beppu, Yaping Shou, Ariful Haque, Richard C. Woodman, Hagop M. Kantarjian, Timothy P. Hughes, Dong-Wook Kim, Giuseppe Saglio
Author Affiliations
1 Fred Hutchinson Cancer Research Center, USA
Presented at
51st American Society of Hematology Annual Meeting 2009
Abstract
Competing Interests

Radich: Novartis Consultancy, Honoraria, Research Funding. Hochhaus: Novartis Research Funding. Branford: Novartis Pharmaceuticals Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Bristol-Myers Squib (BMS)b Honoraria, Research Funding. Shou: Novartis Employment. Haque: Novartis Employment. Woodman: Novartis Employment. Kantarjian: Novartis Research Funding. Hughes: BMS Advisor, Honoraria, Research Funding; Novartis Advisor, Honoraria, Research Funding. Kim: Novartis Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; BMS Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Wyeth Research Funding. Saglio: Novartis Consultancy, Speakers Bureau; BMS Consultancy, Speakers Bureau.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.